[16–19]SCN5A loss-of-function mutations further reduce sodium influx and shorten action potential duration, increasing the risk of AF.[17] The gain-of-function mutation of SCN5A may promote AF by increasing the excitability of atrial myocytes. The gene discussed is SCN5A; the disease is atrial fibrillation.